Greetings, dear readers. Today, we delve into the exciting realm of oncology, particularly focusing on the cutting-edge T-cell–redirecting strategies that have emerged in the treatment landscape of multiple myeloma. Recent updates from the 2025 ASCO, EHA, and IMS conferences have brought to light remarkable advancements that showcase the evolving nature of cancer therapeutics. The field […]
Unveiling Innovative T-Cell–Redirecting Strategies in Myeloma Post 2025 ASCO, EHA, and IMS Conferences




















































































































































































































































































































































































































































































































































































































